What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements

por Miletic, Nevena, Adam, Sarah, Acquah, Jacqueline, Aziz, Zainab, Joos, Angelika, Mwangi, John M.
Publicado 2023

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action

por Hoos, Anton, Anderson, James, Boutin, Marc, Dewulf, Lode, Geissler, Jan, Johnston, Graeme, Joos, Angelika, Metcalf, Marilyn, Regnante, Jeanne, Sargeant, Ifeanyi, Schneider, Roslyn F., Todaro, Veronica, Tougas, Gervais
Publicado 2015

Historical Data Analyses and Scientific Knowledge Suggest Complete Removal of the Abnormal Toxicity Test as a Quality Control Test

por Garbe, Joerg H O, Ausborn, Susanne, Beggs, Claire, Bopst, Martin, Joos, Angelika, Kitashova, Alexandra A, Kovbasenco, OLga, Schiller, Claus-Dieter, Schwinger, Martina, Semenova, Natalia, Smirnova, Lilia, Stodart, Fraser, Visalli, Thomas, Vromans, Lisette
Publicado 2014

Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches

por Rei Bolislis, Winona, Bejeuhr, Gesine, Benzaghou, Fawzi, Corriol‐Rohou, Solange, Herrero‐Martinez, Esteban, Hildebrand, Heidrun, Hill‐Venning, Claire, Hoogland, Hans, Johnson, Craig, Joos, Angelika, Vart, Richard, Le Visage, Geneviève, Kühler, Thomas C.
Publicado 2021

Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

por Eichler, Hans‐Georg, Bedlington, Nicola, Boudes, Mathieu, Bouvy, Jacoline C., Broekmans, André W., Cerreta, Francesca, Faulkner, Stuart D., Forda, Susan R., Joos, Angelika, Le Cam, Yann, Mayer, Mark H., Pirard, Vinciane, Corriol‐Rohou, Solange
Publicado 2018